Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

SVP, COMM & MEDICAL AFFAIRS

SVP & CHIEF FINANCIAL OFFICER

CHIEF EXECUTIVE OFFICER

SVP, GEN COUNSEL AND SECRETARY

SVP, DEV & HEAD OF IRE OFFICE

SVP, RESEARCH & DEVELOPMENT

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). The company's product includes Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; and TRELEGY for the treatment of COPD and asthma. It has licensing and collaboration agreements with Pfizer Inc. for its preclinical skin-selective pan-JAK inhibitor program, as well as Viatris Inc. Theravance Biopharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United State...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-02	Premium	acquired	Premium	Premium	Premium	SVP, COMM & MEDICAL AFFAIRS
2024-04-02	Premium	acquired	Premium	Premium	Premium	SVP & CHIEF FINANCIAL OFFICER
2024-04-02	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-04-02	Premium	acquired	Premium	Premium	Premium	SVP, GEN COUNSEL AND SECRETARY
2024-04-02	Premium	acquired	Premium	Premium	Premium	SVP, DEV & HEAD OF IRE OFFICE
2024-03-15	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-03-15	Premium	gifted	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-03-15	Premium	gifted	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-02-22	Premium	sold	Premium	Premium	Premium	SVP, COMM & MEDICAL AFFAIRS
2024-02-20	Premium	sold (taxes)	Premium	Premium	Premium	SVP, RESEARCH & DEVELOPMENT
2024-02-20	Premium	sold (taxes)	Premium	Premium	Premium	SVP, COMM & MEDICAL AFFAIRS
2024-02-20	Premium	sold (taxes)	Premium	Premium	Premium	SVP & CHIEF FINANCIAL OFFICER
2024-02-20	Premium	sold (taxes)	Premium	Premium	Premium	SVP, DEV & HEAD OF IRE OFFICE
2024-02-20	Premium	sold (taxes)	Premium	Premium	Premium	SVP, GEN COUNSEL AND SECRETARY
2024-02-20	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2023-12-21	Premium	acquired	Premium	Premium	Premium	-
2023-11-21	Premium	sold	Premium	Premium	Premium	SVP, COMM & MEDICAL AFFAIRS
2023-11-20	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2023-11-20	Premium	sold (taxes)	Premium	Premium	Premium	SVP, RESEARCH & DEVELOPMENT
2023-11-20	Premium	sold (taxes)	Premium	Premium	Premium	SVP, COMM & MEDICAL AFFAIRS
2023-11-20	Premium	sold (taxes)	Premium	Premium	Premium	SVP, GEN COUNSEL AND SECRETARY
2023-11-20	Premium	sold (taxes)	Premium	Premium	Premium	SVP & CHIEF FINANCIAL OFFICER
2023-11-14	Premium	sold	Premium	Premium	Premium	SVP, RESEARCH & DEVELOPMENT
2023-10-30	Premium	acquired	Premium	Premium	Premium	SVP, RESEARCH & DEVELOPMENT
2023-10-16	Premium	sold	Premium	Premium	Premium	SVP, RESEARCH & DEVELOPMENT

TBPH - Theravance Biopharma Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for TBPH